Neuland Laboratories Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 | Sep-26 |
|---|---|---|---|---|---|---|---|---|
| 398 | 328 | 293 | 514 | 440 | 776 | 642 | 450 | |
| 4 | 7 | 8 | 2 | 8 | 12 | 8 | 8 | |
| — | — | — | — | 440 | — | — | — | |
| 330 | 297 | 283 | 387 | 393 | 501 | 452 | 388 | |
| 145 | 141 | 161 | 228 | 200 | 231 | 229 | 216 | |
| 21 | −14 | −48 | −44 | −11 | 39 | −8 | −65 | |
| 69 | 66 | 73 | 80 | 89 | 98 | 106 | 102 | |
| 2 | 2 | 5 | 5 | 7 | 7 | 7 | 7 | |
| 16 | 17 | 20 | 23 | 24 | 25 | 27 | 29 | |
| 76 | 84 | 71 | 95 | 85 | 101 | 91 | 99 | |
| 146 | 59 | 42 | 157 | 85 | 320 | 231 | 105 | |
| 130 | 42 | 22 | 135 | 61 | 295 | 205 | 76 | |
| 56 | — | — | — | — | — | — | — | |
| 128 | 39 | 18 | 129 | 54 | 287 | 198 | 69 | |
| 26 | 11 | 4 | 33 | 14 | 75 | 50 | 17 | |
| 102 | 28 | 14 | 97 | 41 | 213 | 148 | 52 | |
| Financial ratios | ||||||||
| 36.75% | 17.83% | 14.46% | 30.60% | 19.37% | 41.20% | 36.06% | 23.36% | |
| 25.52% | 8.47% | 4.75% | 18.83% | 9.23% | 27.40% | 23.02% | 11.48% | |
| 79.18 | 21.67 | 10.83 | 75.49 | 31.62 | 165.76 | 115.10 | 40.24 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.